The purpose of this study is to see if the study drug is safe and able to reduce irritability in pediatric patients ages 5-17 with Autism Spectrum Disorder (ASD).
Eligibility Criteria:
Participants in this study will receive all study related medical care and examinations at no cost to them or their insurance.
If you would like to hear more about this trial, or see if you qualify to participate, please contact us at 801.409.2040. You can also reach us via e-mail or by submitting an interest form by clicking the button below.
